Mucosal production of antigastric autoantibodies in Helicobacter pylori gastritis

被引:14
|
作者
Faller, G
Ruff, S
Reiche, N
Hochberger, J
Hahn, EG
Kirchner, T
机构
[1] Univ Erlangen Nurnberg, Inst Pathol, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Dept Internal Med 1, D-91054 Erlangen, Germany
关键词
D O I
10.1046/j.1523-5378.2000.00020.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Apart form bacterial virulence factors of Helicobacter pylori, certain host factors influence the pathogenesis of H. pylori gastritis. In particular, antigastric autoantibodies that are detectable in the sera of a substantial proportion of H. pylori were shown to correlate with the development of gastric atrophy. The aim of this study was to analyze the possible antigastric autoimmune response in H. pylori gastritis at the site where the action is, i.e., in the gastric mucosa. Materials and Methods. Gastric biopsy specimens from antrum and corpus mucosa of 24 H. pylori-infected and of 33 noninfected patients were cultured for 3 days, and tissue culture supernatants were analyzed for the amount of locally produced IgA and IgG. Antigastric autoantibodies were screened in the sera and in the supernatants by means of immunohistochemistry. Results. The infected patients had significantly higher concentrations of locally produced IgA, whereas the IgG concentrations were virtually the same in infected and noninfected patients. IgG or IgA antigastric autoantibodies, or both, were detectable only in the sera (38%) and supernatants (17%) of infected patients. Interestingly, the patient with the strongest local autoimmune response showed body-predominant H. pylori gastritis, with destruction of gastric glands and atrophy of the body mucosa. Conclusions. These results demonstrate that antigastric autoimmune reactions are detectable at the site of the disease and might be relevant for the pathogenesis of gastric mucosa atrophy in H. pylori gastritis.
引用
收藏
页码:129 / 134
页数:6
相关论文
共 50 条
  • [31] Helicobacter pylori and granulomatous gastritis
    Roblin, X
    Boudemaghe, T
    Paris, F
    Pellissier, L
    Le Gall, S
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2002, 26 (04): : 416 - 417
  • [32] Helicobacter pylori gastritis—Epidemiology
    Pentti Sipponen
    Journal of Gastroenterology, 1997, 32 : 273 - 277
  • [33] GASTRITIS AND HELICOBACTER-PYLORI
    SHEE, V
    NEVES, B
    BAPTISTA, C
    QUINA, M
    GASTROENTEROLOGY, 1995, 108 (04) : A248 - A248
  • [34] Immunopathology of Helicobacter pylori gastritis
    Kirchner, T
    Steininger, H
    Faller, G
    DIGESTION, 1997, 58 : 14 - 16
  • [35] HELICOBACTER-PYLORI AND GASTRITIS
    DRUMM, B
    SHERMAN, P
    DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (06) : 962 - 962
  • [36] Helicobacter pylori gastritis in Africa
    Kuipers, EJ
    Meijer, GA
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (06) : 601 - 603
  • [37] Helicobacter pylori and the evolution of gastritis
    Stolte, M
    Eidt, S
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 : 13 - 16
  • [38] HELICOBACTER-PYLORI AND GASTRITIS
    GUERRE, J
    GAZETTE MEDICALE, 1990, 97 (36): : 31 - 33
  • [39] Autoantibodies reacting with gastric antigens in Helicobacter pylori associated body gastritis of dyspeptic children
    Ierardi, E
    Francavilla, R
    Balzano, T
    Negrini, R
    Francavilla, A
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 30 (05): : 478 - 480
  • [40] Increased mucosal production of monomeric IgA1 but no IgA1 protease activity in Helicobacter pylori gastritis
    Berstad, AE
    Valnes, KN
    Kilian, M
    Brandtzaeg, P
    GUT, 1998, 43 : A30 - A30